60441-79-4

Basic information

• Product Name: METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE
• Synonyms: METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE;METHYL-3,5-DIMETHOXY-P-TOLUATE;3,5-Dimethoxy-p-toluic acid methyl ester (COOCH3=1)
• CAS NO: 60441-79-4
• Molecular Formula: C₁₁H₁₄O₄
• Molecular Weight: 210.23
• Product Categories: Aromatic Esters;Acids & Esters;Anisoles, Alkyloxy Compounds & Phenylacetates
• Mol File: 60441-79-4.mol
• Article Data: 10

Chemical Properties

• Boiling Point: 303.6°C at 760 mmHg
• Flash Point: 131.4°C
• Appearance: /
• Density: 1.097g/cm³
• Vapor Pressure: 0.000922mmHg at 25°C
• Refractive Index: 1.498
• Solubility: Dichloromethane
• CAS DataBase Reference: METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE(CAS DataBase Reference)
• NIST Chemistry Reference: METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE(60441-79-4)
• EPA Substance Registry System: METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE(60441-79-4)

Safety Data

• Hazardous Substances Data: 60441-79-4(Hazardous Substances Data)

Usage

Description

METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE, a chemical compound with the molecular formula C11H14O4, is a derivative of benzoic acid and belongs to the class of organic compounds known as m-xylenes. It is characterized by its sweet, floral aroma.
Used in Fragrance and Flavor Industry:
METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE is used as a synthetic flavoring agent for its sweet, floral aroma, making it suitable for the production of perfumes, soaps, and other scented products.
Used as a Chemical Intermediate:
METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE is also utilized in the synthesis of other organic compounds, contributing to the development of various chemical products.
It is crucial to handle METHYL 3,5-DIMETHOXY-4-METHYLBENZOATE with care due to its potential hazards if not properly managed.

InChI:InChI=1/C11H14O4/c1-7-9(13-2)5-8(11(12)15-4)6-10(7)14-3/h5-6H,1-4H3

Upstream product

• 186581-53-3 diazomethane 
• 61040-81-1 4-methyl-3,5-dimethoxybenzoic acid 
• 75238-29-8 3,5-dihydroxy-4-methylbenzoic acid methyl ester 
• 28026-96-2 3,5-dihydroxy-4-methylbenzoic acid 
• 77-78-1 dimethyl sulfate 
• 74-88-4 methyl iodide 
• 74896-66-5 Methyl 3,5-Dibromo-4-methylbenzoate 
• 67-56-1 methanol 
• 78025-94-2 4-cyano-2,6-dimethoxytoluene 
• 874514-68-8 (4-carboxy-2,6-dimethoxy-phenyl)-acetic acid 
• 21390-25-0 1,3-dimethoxy-2,5-dimethylbenzene 
• 6971-52-4 3-methoxy-2-methylphenol 
• 608-25-3 2-methylbenzene-1,3-diol 
• 7577-74-4 6-acetoxy-6-methylcyclohexa-2,4-dienone 

Downstream Products

• 61040-81-1 4-methyl-3,5-dimethoxybenzoic acid 
• 76447-17-1 Methyl 4-Methyl-3,5-dimethoxy-2-nitrobenzoate 
• 104447-91-8 methyl 4-bromomethyl-3,5-dimethoxybenzoate 
• 717916-63-7 5-iodomethyl-1,3-dimethoxy-2-methyl-benzene 
• 717916-64-8 (S)-3-(3,5-Dimethoxy-4-methyl-phenyl)-2-methyl-propan-1-ol 
• 717916-65-9 (2S,3R,4S)-1-(3,5-Dimethoxy-4-methyl-phenyl)-2,4-dimethyl-hex-5-en-3-ol 
• 717916-66-0 (2R,3R,4S)-3-(tert-Butyl-dimethyl-silanyloxy)-5-(3,5-dimethoxy-4-methyl-phenyl)-2,4-dimethyl-pentanal 
• 717916-67-1 (2S,3R,4S,5R,8S)-3,9-Bis-(tert-butyl-dimethyl-silanyloxy)-1-(3,5-dimethoxy-4-methyl-phenyl)-2,4,8-trimethyl-nonan-5-ol 
• 717916-77-3 Acetic acid (1R,2S,3R,4S)-3-(tert-butyl-dimethyl-silanyloxy)-1-[(S)-4-(tert-butyl-dimethyl-silanyloxy)-3-methyl-butyl]-5-(3,5-dimethoxy-4-methyl-phenyl)-2,4-dimethyl-pentyl ester 
• 717916-62-6 (2-{(2R,3S,4S,5S,6R)-4-(tert-Butyl-dimethyl-silanyloxy)-6-[(S)-4-(tert-butyl-dimethyl-silanyloxy)-3-methyl-butyl]-3,5-dimethyl-tetrahydro-pyran-2-yl}-3,4,6-trimethoxy-5-methyl-phenyl)-acetaldehyde 
• 717916-75-1 (2R,3S,4S,5S,6R)-2-(2-Allyl-3,5,6-trimethoxy-4-methyl-phenyl)-4-(tert-butyl-dimethyl-silanyloxy)-6-[(S)-4-(tert-butyl-dimethyl-silanyloxy)-3-methyl-butyl]-3,5-dimethyl-tetrahydro-pyran 
• 717916-74-0 2-Allyl-3-{(2R,3S,4S,5S,6R)-4-(tert-butyl-dimethyl-silanyloxy)-6-[(S)-4-(tert-butyl-dimethyl-silanyloxy)-3-methyl-butyl]-3,5-dimethyl-tetrahydro-pyran-2-yl}-5-methoxy-6-methyl-benzene-1,4-diol 

Relevant articles and documents

A Convenient Synthesis of 3,5-Dimethoxy-4-methylbenzoic Acid

-

COMPOUNDS WITH 7-MEMBER CYCLE AND THE PHARMACEUTICAL USE THEREOF FOR PREVENTING AND TREATING DIABETES AND METABOLISM SYNDROME

The invention discloses a new use of a class of heptacyclic compounds in the preparation of formulations for the prevention and treatment of diabetes and metabolic syndromes; the present invention also discloses a new class of heptacyclic compounds; the present invention also discloses a process for preparing the heptacyclic compounds and a composition containing the same. The heptacyclic compounds of the present invention can be used to effectively preventing or treating diseases such as diabetes and metabolic syndromes.

Approaches to the fully functionalized DEF ring system of ristocetin A via highly selective ruthenium-promoted SNAr reaction

Ruthenium-promoted intramolecular SNAr reaction has allowed the construction of the fully functionalized 16-membered DEF macrocycle 4 of ristocetin A that incorporates the required arylglycine and arylserine residues as the F and E ring, respectively.